These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 793369

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE.
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [Abstract] [Full Text] [Related]

  • 7. Clinical use and pharmacology of amiodarone.
    Heger JJ, Prystowsky EN, Miles WM, Zipes DP.
    Med Clin North Am; 1984 Sep; 68(5):1339-66. PubMed ID: 6387328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E, Krikler DM.
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN, Anderson KP, Winkle RA, Swerdlow CD, Mason JW.
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [Abstract] [Full Text] [Related]

  • 17. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
    Leak D.
    Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K, Hendrickson J, Kannan R, Singh BN.
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract] [Full Text] [Related]

  • 20. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
    Waxman HL, Groh WC, Marchlinski FE, Buxton AE, Sadowski LM, Horowitz LN, Josephson ME, Kastor JA.
    Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.